Venture Capital Investors

Venture Investors

Venture Investors is a venture capital investment firm that helps tech companies with financing and expertise.

Venture Investor Overview

Venture Investor
Venture Investors
Status
Active
Investor Type
Venture Capital
Activity Level
78 transactions
Funds Raised
At least $197.6 million
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services
Medical Devices & Instruments

Contact Information

Contact
John Neis
Title
Managing Director
Mailing Address
505 S Rosa Rd. 201
Madison, WI 53719
USA
Phone
(608) 441-2700
Website
www.ventureinvestors.com
Email Address
[email protected]

Background Information

Overview
Venture Investors is one of the premier providers of seed and early stage venture capital in the Midwest. Formed in 1982, Venture Investors has a proven track record of identifying and financing world-class technology companies throughout the Midwest, delivering top quartile returns to its investors.
Profile
Venture Investors LinkedIn Company Profile
Social Media
Venture Investors Company Twitter Account
Company News
Venture Investors News
Facebook
Venture Investors on Facebook
YouTube
Venture Investors on YouTube
Last Transaction
10/10/2024

Transaction History

Our records indicate that Venture Investors invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Rivermark Medical
10/10/2024
$30,000,000
HistoSonics
8/15/2024
$102,000,000
EarliTec Diagnostics
4/2/2024
$21,500,000
ViaLase
4/1/2024
$40,000,000
Elephas Biosciences
1/23/2024
$55,000,000
Visana Health
8/17/2023
$10,100,000
HistoSonics
12/13/2022
$85,000,000
Delphinus Medical Technologies
9/29/2022
$30,000,000
EnsoData
6/3/2022
$20,000,000
Iterion Therapeutics
2/17/2021
$17,000,000
EnsoData
6/11/2020
$9,000,000
HistoSonics
6/9/2020
$40,000,000
HistoSonics
4/9/2019
$54,000,000
Eximis Surgical
11/12/2018
$7,500,000
HealthMyne
8/2/2018
$15,000,000
Delphinus Medical Technologies
3/31/2016
$10,740,000
FluGen
3/31/2016
$3,388,000
Madison Vaccines
3/31/2016
$1,516,000
Elucent Medical
3/31/2016
$7,250,000
SkySpecs
11/9/2015
$3,000,000
TAI Diagnostics
10/27/2015
$8,200,000
Tamir Biotechnology
9/30/2015
$800,000
Delphinus Medical Technologies
9/10/2015
$39,500,000
ReShape Medical
8/26/2015
$38,000,000
NeuMoDx Molecular
6/30/2015
$10,547,000
Silatronix
6/30/2015
$2,000,000
NeuWave Medical
5/28/2015
$25,000,000
HealthMyne
3/12/2015
$4,500,000
Madison Vaccines
12/31/2014
$4,059,000
Great Lakes Pharmaceuticals
9/30/2014
$11,221,000
Juventas Therapeutics
9/30/2014
$5,000,000
Thalchemy
6/26/2014
$650,000
Aerpio Pharmaceuticals
4/23/2014
$22,000,000
NeuMoDx Molecular
4/2/2014
$21,000,000
Neurovance
4/1/2014
$6,300,000
Madison Vaccines
1/14/2014
$8,000,000
Silatronix
12/31/2013
$700,000
Aerpio Pharmaceuticals
11/6/2013
$9,000,000
UpTo
7/12/2013
$500,000
Neurovance
6/30/2013
$3,000,000
Nextt
6/19/2013
$700,000
Akebia Therapeutics
6/5/2013
$41,000,000
NetSocket
4/2/2013
$9,200,000
ReShape Medical
3/31/2013
$6,915,000
Akebia Therapeutics
3/31/2013
$2,500,000
HistoSonics
12/31/2012
$3,034,000
BlueWillow Biologics
11/29/2012
$11,000,000
Neurovance
10/16/2012
$7,000,000
Akebia Therapeutics
9/30/2012
$2,500,100
Aerpio Pharmaceuticals
9/1/2012
$27,000,000
NeuWave Medical
8/6/2012
$14,000,000
Juventas Therapeutics
7/17/2012
$22,200,000
Euthymics Bioscience
6/30/2012
$3,709,200
Chromatin
3/31/2012
$1,600,800
Neurovance
3/31/2012
$163,200
Inviragen
3/31/2012
$5,454,000
Euthymics Bioscience
3/31/2012
$1,927,200
Akebia Therapeutics
1/9/2012
$4,100,000
ProCertus BioPharm
6/30/2011
$1,700,000
NeuWave Medical
6/30/2011
$2,625,000
Mithridion
1/11/2011
$1,250,000
NeuWave Medical
12/31/2010
$5,552,000
Inviragen
12/31/2010
$5,455,200
Euthymics Bioscience
7/22/2010
$24,000,000
HistoSonics
1/4/2010
$11,000,000
Inviragen
12/31/2009
$15,000,000
ProCertus BioPharm
12/31/2009
$2,230,000
ProCertus BioPharm
6/30/2009
$2,100,000
Mithridion
1/12/2009
$2,900,000
Incept BioSystems
9/30/2008
$1,625,000
Mithridion
6/5/2008
$2,300,000
Nerites
2/15/2008
$5,700,000
Cellectar
1/8/2008
$13,000,000
Virent Energy Systems
9/5/2007
$21,000,000
ProCertus BioPharm
5/10/2007
$2,300,000
Incept BioSystems
4/26/2007
$3,250,000
Mithridion
4/17/2007
$1,200,000
Virent Energy Systems
6/8/2006
$7,500,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
James Adox
  James Adox LinkedIn Profile  James Adox Twitter Account  James Adox News  James Adox on Facebook
Managing Director
Scott Button
  Scott Button LinkedIn Profile  Scott Button Twitter Account  Scott Button News  Scott Button on Facebook
Managing Director
Roger Ganser
  Roger Ganser LinkedIn Profile  Roger Ganser Twitter Account  Roger Ganser News  Roger Ganser on Facebook
Managing Director
John Neis
  John Neis LinkedIn Profile  John Neis Twitter Account  John Neis News  John Neis on Facebook
Managing Director
Paul Weiss
  Paul Weiss LinkedIn Profile  Paul Weiss Twitter Account  Paul Weiss News  Paul Weiss on Facebook

 

Funds

Our database includes the following fund closing(s) for Venture Investors. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Venture Investors Early Stage Fund V
7/26/2012
$80,000,000
Venture Investors Early Stage Fund IV
9/17/2007
$117,625,000

 

Portfolio Companies

Venture Investors has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Aerpio Pharmaceuticals
Akebia Therapeutics
BlueWillow Biologics
Cellectar
Chromatin
Delphinus Medical Technologies
EarliTec Diagnostics
Elephas Biosciences
Elucent Medical
EnsoData
Euthymics Bioscience
Eximis Surgical
FluGen
Great Lakes Pharmaceuticals
HealthMyne
HistoSonics
Incept BioSystems
Inviragen
Iterion Therapeutics
Juventas Therapeutics
Madison Vaccines
Mithridion
Nerites
NetSocket
NeuMoDx Molecular
Neurovance
NeuWave Medical
Nextt
ProCertus BioPharm
ReShape Medical
Rivermark Medical
Silatronix
SkySpecs
TAI Diagnostics
Tamir Biotechnology
Thalchemy
UpTo
ViaLase
Virent Energy Systems
Visana Health

 

 

 

 

Browse more venture capital investors:

Venture Investment Associates | Venture Kick

 

Share this article

 

About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.